« Previous
Next »
Journal of the Neurological Sciences
Volume 291, Issue 1
, Pages 52-56
, 15 April 2010
Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen
References
- . The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53:1107–1114
- . Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485–1489
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–2112
- NMO-IgG in the diagnosis of neuromyelitis optica. Neurology. 2007;68:1076–1077
- NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008;70:2197–2200
- Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006;59:566–569
- . IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473–477
- Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol. 2008;65:913–919
- Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med. 2006;210:307–313
- Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 2007;4:e133
- Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007;130:1235–1243
- Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol. 2008;196:181–187
- Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult Scler. 2009;15:834–847
- . The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805–815
- Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121–127
- . Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport. Neuroscience. 2004;129:999–1010
- Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica. J Neuroimmunol. 2009;211:110–113
- Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007;69:2221–2231
- Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain. 2008;131:3072–3080
- Western blot analysis for the detection of serum antibodies recognizing linear aquaporin-4 epitopes in patients with Neuromyelitis Optica. J Neuroimmunol. 2009;217:74–79
- . An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005;64:1270–1272
- Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol. 2008;65:1443–1448
PII: S0022-510X(10)00010-9
doi: 10.1016/j.jns.2010.01.002
© 2010 Elsevier B.V. All rights reserved.
« Previous
Next »
Journal of the Neurological Sciences
Volume 291, Issue 1
, Pages 52-56
, 15 April 2010
